Try a new search

Format these results:

Searched for:

in-biosketch:true

person:husais06

Total Results:

172


Impact of the Current Versus the Previous Diagnostic Threshold on the Outcome of Patients With Borderline Changes Suspicious for T Cell-mediated Rejection Diagnosed on Indication Biopsies

McRae, Michael; Bouchard-Boivin, François; Béland, Stéphanie; Noël, Réal; Côté, Isabelle; Lapointe, Isabelle; Lesage, Julie; Latulippe, Eva; Riopel, Julie; Santoriello, Dominick; Husain, Syed A; Désy, Olivier; Houde, Isabelle; Batal, Ibrahim; De Serres, Sacha A
BACKGROUND:Since the borderline changes suspicious for acute T cell-mediated rejection (BL) category was broadened, there has been a debate regarding the right threshold for tubulitis and interstitial inflammation scores. METHODS:We studied a first cohort of 111 patients with BL found on an indication biopsy between 2006 and 2016 and compared those with scores of t1i0 (BLt1i0) to those with higher scores (BL≥t1i1). A second cohort of 56 patients with BL was used for external validation. We used a composite endpoint of death-censored graft failure or doubling of the serum creatinine level postbiopsy. RESULTS:In the first cohort, 68% (75/111) of the BL cases fell in the BLt1i0 group. At 5 years, the occurrence of the composite endpoint was 5% and 14% for BLt1i0 and BL≥t1i1, respectively. In contrast, the endpoint occurred in 5% of nonrejectors and 21% of patients with T cell-mediated rejection. In the validation cohort, 8% versus 36% of BLt1i0 and BL≥t1i1 reached the endpoint, respectively. Multivariable Cox modeling revealed that BLt1i0 patients had a prognosis similar to that of nonrejectors (adjusted hazard ratio, 0.6; 95% confidence interval, 0.1-2.2; P = 0.40) but better than that of patients with BL≥t1i1 (hazard ratio, 3.8; 95% confidence interval, 1.3-11.5; P = 0.02). Sensitivity analyses restricted to death-censored graft loss or using time posttransplant as the time of reference provided similar results. CONCLUSIONS:In summary, patients with BLt1i0 have a different prognosis to that of BL≥t1i1 patients, which brings into question the current diagnostic thresholds.
PMID: 29916985
ISSN: 1534-6080
CID: 5867062

Patients prioritize waitlist over posttransplant outcomes when evaluating kidney transplant centers

Husain, Syed Ali; Brennan, Corey; Michelson, Ariane; Tsapepas, Demetra; Patzer, Rachel E; Schold, Jesse D; Mohan, Sumit
Factors that patients value when choosing a transplant center have not been well studied. In order to guide the improvement of patient-facing materials, we conducted an anonymous electronic survey of patients that assessed the relative importance of patient experience, practical considerations, transplant center reputation, center experience, and waitlist when selecting a transplant center. A total of 409 respondents completed the survey, of whom 68% were kidney transplant recipients and 32% had chronic kidney disease or were on dialysis. Participants had mean age 56 ± 12 years and were predominantly female (61%), white (79%), and had an associate's degree or higher (68%). Participants most often prioritized waitlist when evaluating transplant centers (transplanted 26%, chronic kidney disease 40%), and waitlist was almost twice as likely as outcomes to be ranked most important (30% vs 17%). Education level and transplant status were significantly associated with factors used for center prioritization. Waitlisted respondents most commonly (48%) relied on physicians for information when selecting a center, while a minority cited transplant-specific organizations. In order to improve shared decision-making, materials outlining center-specific waitlist features should be prioritized. Novel patient-oriented metrics for measuring transplant center quality that align with patient priorities must be explored.
PMID: 29945305
ISSN: 1600-6143
CID: 5867072

Kidney transplant offers to deceased candidates [Letter]

Husain, S Ali; Winterhalter, F Sara; Mohan, Sumit
PMID: 30091841
ISSN: 1600-6143
CID: 5867082

Association between the "Timed Up and Go Test" at transplant evaluation and outcomes after kidney transplantation

Michelson, Ariane T; Tsapepas, Demetra S; Husain, S Ali; Brennan, Corey; Chiles, Mariana C; Runge, Brian; Lione, Jennifer; Kil, Byum H; Cohen, David J; Ratner, Lloyd E; Mohan, Sumit
BACKGROUND:Studies have demonstrated the Timed Up and Go Test's (TUGT) ability to forecast postoperative outcomes for several surgical specialties. Evaluations of the TUGT for waitlist and posttransplant outcomes have yet to be examined in kidney transplantation. OBJECTIVE:To assess the prognostic utility of the TUGT and its associations with waitlist and posttransplant outcomes for kidney transplant candidates. DESIGN AND METHODS:Single-center, prospective study of 518 patients who performed TUGT during their transplant evaluation between 9/1/2013-11/30/2014. TUGT times were evaluated as a continuous variable or 3-level discrete categorical variable with TUGT times categorized as long (>9 seconds), average (8-9 seconds), or short (5-8 seconds). RESULTS:Transplanted individuals had shorter TUGT times than those who remained on the waitlist (8.99 vs 9.79 seconds, P < 0.001). Bivariable and multivariable logistic regression showed that after adjusting for age, there was no association between TUGT times and probability of waitlist removal (OR 0.997 [0.814-1.221]), prolonged length of stay posttransplant (OR 1.113 [0.958-1.306] for deceased donor, OR 0.983 [0.757-1.277] for living donor), and 30-day readmissions (OR 0.984 [0.845-1.146] for deceased donor, OR 1.254 [0.976-1.613] for living donor). CONCLUSIONS:The TUGT was not associated with waitlist removal or prolonged hospitalization for kidney transplant candidates. Alternative assessments of global health, such as functional status or frailty, should be considered for evaluation of potential kidney transplant candidates.
PMCID:6265056
PMID: 30230036
ISSN: 1399-0012
CID: 5867092

Creatinine- versus cystatin C-based renal function assessment in the Northern Manhattan Study

Husain, S Ali; Willey, Joshua Z; Park Moon, Yeseon; Elkind, Mitchell S V; Sacco, Ralph L; Wolf, Myles; Cheung, Ken; Wright, Clinton B; Mohan, Sumit
BACKGROUND:Accurate glomerular filtration rate estimation informs drug dosing and risk stratification. Body composition heterogeneity influences creatinine production and the precision of creatinine-based estimated glomerular filtration rate (eGFRcr) in the elderly. We compared chronic kidney disease (CKD) categorization using eGFRcr and cystatin C-based estimated GFR (eGFRcys) in an elderly, racially/ethnically diverse cohort to determine their concordance. METHODS:The Northern Manhattan Study (NOMAS) is a predominantly elderly, multi-ethnic cohort with a primary aim to study cardiovascular disease epidemiology. We included participants with concurrently measured creatinine and cystatin C. eGFRcr was calculated using the CKD-EPI 2009 equation. eGFRcys was calculated using the CKD-EPI 2012 equation. Logistic regression was used to estimate odds ratios and 95% confidence intervals of factors associated with reclassification from eGFRcr≥60ml/min/1.73m2 to eGFRcys<60ml/min/1.73m2. RESULTS:Participants (n = 2988, mean age 69±10yrs) were predominantly Hispanic, female, and overweight/obese. eGFRcys was lower than eGFRcr by mean 23mL/min/1.73m2. 51% of participants' CKD status was discordant, and only 28% maintained the same CKD stage by both measures. Most participants (78%) had eGFRcr≥60mL/min/1.73m2; among these, 64% had eGFRcys<60mL/min/1.73m2. Among participants with eGFRcr≥60mL/min/1.73m2, eGFRcys-based reclassification was more likely in those with age >65 years, obesity, current smoking, white race, and female sex. CONCLUSIONS:In a large, multiethnic, elderly cohort, we found a highly discrepant prevalence of CKD with eGFRcys versus eGFRcr. Determining the optimal method to estimate GFR in elderly populations needs urgent further study to improve risk stratification and drug dosing.
PMCID:6235352
PMID: 30427947
ISSN: 1932-6203
CID: 5867112

Outcomes for potential kidney transplant recipients offered public health service increased risk kidneys: A single-center experience

Fernandez, Hilda E; Chiles, Mariana C; Pereira, Marcus; Husain, Syed Ali; Miko, Benjamin; Baral, Prativa; Dale, Leigh-Anne; Patel, Shefali; Runge, Brian; Tsapepas, Demetra; Sandoval, Pedro Rodrigo; Ratner, Lloyd E; Cohen, David J; Mohan, Sumit
BACKGROUND:Discard rate of Public Health Service Increased Risk (PHS-IR) organs is high despite the absence of worse kidney transplant outcomes. METHODS:We conducted a retrospective, single-center study of PHS-IR kidney offers made to kidney transplant-only potential recipients from 6/2004 to 5/2015. Overall mortality and transplant outcomes between potential recipients were stratified by response to PHS-IR kidney offers. Cox regression and Kaplan-Meier analyses of mortality and allograft failure were performed. RESULTS:A total of 2423 potential recipients were offered a PHS-IR kidney, with 1502 transplanted, with or without a PHS-IR kidney. Predictors of accepting a PHS-IR kidney included higher Estimated Post Transplant Survival (EPTS) score, prior kidney transplant, and lower educational achievement on multivariable analysis (P = 0.025, P = 0.004, P = 0.023). A positive response to a PHS-IR kidney was associated with lower risk of mortality (3.63% vs 11.6%; aHR 0.467, P = 0.0008). PHS-IR kidney recipients had decreased risk of allograft loss compared to non-PHS-IR recipients (P = 0.007), though mortality outcomes were not significantly different based on PHS-IR status (P = 0.38). No transmission of HIV, HBV, or HCV occurred from PHS-IR kidney donors in this cohort. CONCLUSIONS:Efforts must be made to increase awareness of the beneficial outcomes of PHS-IR organs to maximize appropriate donor allocation.
PMID: 30329179
ISSN: 1399-0012
CID: 4994102

Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts

Santoriello, Dominick; Husain, Syed A; De Serres, Sacha A; Bomback, Andrew S; Crew, Russell J; Vasilescu, Elena-Rodica; Serban, Geo; Campenot, Eric S; Kiryluk, Krzysztof; Mohan, Sumit; Hawkins, Gregory A; Hicks, Pamela J; Cohen, David J; Radhakrishnan, Jai; Stokes, Michael B; Markowitz, Glen S; Freedman, Barry I; D'Agati, Vivette D; Batal, Ibrahim
Collapsing focal segmental glomerulosclerosis (cFSGS) in the native kidney is associated with heavy proteinuria and accelerated renal failure. However, cFSGS in the renal allograft is less well characterized. Here we report clinico-pathologic features and APOL1 donor risk genotypes in 38 patients with de novo post-kidney transplant cFSGS. Recipients were 34% female and 26% African American. Concurrent viral infections and acute vaso-occlusion (including thrombotic microangiopathy, cortical necrosis, atheroembolization, and cardiac arrest with contralateral graft thrombosis) were present in 13% and 29% of recipients, respectively. Notably, 61% of patients had concurrent acute rejection and 47% received grafts from African American donors, of which 53% carried APOL1 high-risk genotypes. These frequencies of acute rejection and grafts from African American donors were significantly higher than in our general transplant population (35% and 16%, respectively). Patients had a median serum creatinine of 5.4 mg/dl, urine protein/creatinine 3.5 g/g, and 18% had nephrotic syndrome. Graft failure occurred in 63% of patients at an average of eighteen months post-index biopsy. By univariate analysis, donor APOL1 high-risk genotypes, post-transplant time, nephrotic syndrome, and chronic histologic changes were associated with inferior graft survival while acute vaso-occlusion was associated with superior graft survival. Donor APOL1 high-risk genotypes independently predicted poor outcome. Compared to native kidney cFSGS, post-transplant cFSGS had more acute vaso-occlusion but less proteinuria. Thus, de novo cFSGS is associated with variable proteinuria and poor prognosis with potential predisposing factors of African American donor, acute rejection, viral infection and acute vaso-occlusion. Additionally, donor APOL1 high-risk genotypes are associated with higher incidence and worse graft survival.
PMCID:6251748
PMID: 30287079
ISSN: 1523-1755
CID: 3659072

Procurement Biopsies in the Evaluation of Deceased Donor Kidneys

Carpenter, Dustin; Husain, S Ali; Brennan, Corey; Batal, Ibrahim; Hall, Isaac E; Santoriello, Dominick; Rosen, Raphael; Crew, R John; Campenot, Eric; Dube, Geoffrey K; Radhakrishnan, Jai; Stokes, M Barry; Sandoval, P Rodrigo; D'Agati, Vivette; Cohen, David J; Ratner, Lloyd E; Markowitz, Glen; Mohan, Sumit
BACKGROUND AND OBJECTIVES/OBJECTIVE:Biopsies taken at deceased donor kidney procurement continue to be cited as a leading reason for discard; however, the reproducibility and prognostic capability of these biopsies are controversial. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS/METHODS:=116 kidneys). RESULTS:=0.15), respectively. Ninety-eight (36%) recipients died, and 56 (21%) allografts failed by the end of follow-up. Reperfusion biopsies were more prognostic than procurement biopsies (hazard ratio for graft failure, 2.02; 95% confidence interval, 1.09 to 3.74 versus hazard ratio for graft failure, 1.30; 95% confidence interval, 0.61 to 2.76), with procurement biopsies not significantly associated with graft failure. CONCLUSIONS:We found that procurement biopsies are poorly reproducible, do not correlate well with paraffin-embedded reperfusion biopsies, and are not significantly associated with transplant outcomes.
PMCID:6302333
PMID: 30361336
ISSN: 1555-905x
CID: 3659112

Predictive Value of Using Initial Versus Terminal Deceased Donor Creatinine to Calculate the Kidney Donor Risk Index [Letter]

Chiles, Mariana C; Husain, S Ali; Skillen, Whitney; Lee, Samnang; Carpenter, Dustin; Pastan, Stephen O; Patzer, Rachel E; Tanriover, Bekir; Mohan, Sumit
PMID: 28416320
ISSN: 1523-6838
CID: 5866982

Lidoderm effectiveness in reducing pain in post-operative unilateral knee replacements patients [Meeting Abstract]

Nafissi A.; Husain S.; Ahmed T.; Fedman D.; Bansal A.; Vitale K.; Jimenez A.; Gusmorino P.
Post-operative pain continues to be one of the most common complications in ambulatory surgery. Uncontrolled pain prolongs hospitalization, hinders recovery and contributes to patient dissatisfaction. Current pain therapies, such as opioids, have several debilitating side effects that include nausea, constipation, and drowsiness, which impact the patient's functional recovery. The objective was to assess Lidoderm (lidocaine 5%) patch effectiveness in reducing pain and opioid use in post-operative unilateral knee replacement patients. This was a randomized, double-blind, placebo-controlled trial. One Lidoderm or placebo patch was cut in half and placed on either side of the incision of the operated knee, for 12-hours on and 12-hours off each day. Both groups continued to receive their regular pain medication as needed, which included acetaminophen/codeine, acetaminophen/hydrocodone, acetaminophen 325mg/oxycodone5 mg (Percocet), hydromorphone, tramadol, and celecoxib. Pain levels were based on a 10-point numerical analog scale and were assessed daily for a total of 7-days. Data from 87 participants were included, 44 in Lidoderm and 43 in placebo group: the mean amount of Percocets used was 24.76 (SD=16.45) in the Lidoderm and 27.76 (SD=22.35) in the placebo group (p=0.64). The mean amount of Percocet use per day was 3.53 (SD=2.34) in the Lidoderm and 3.90 (SD=3.21) in the placebo group (p=0.71). The mean decrease in pain scale for the Lidoderm was 3.01 (SD=2.42) and 2.08 (SD=1.70) for the placebo group, and was significant (p=0.003). No side effects reported. Providing post-operative analgesia is difficult yet imperative to recovery. Patients with lidoderm patches had an overall lower pain level that was statistically significant over a 7-day post-operative period. The average total and daily Percocet use was also lower in the Lidoderm group. Based on our results, we found that placing a topical Lidoderm patch provides an effective adjunct treatment in post-operative pain management
EMBASE:70392149
ISSN: 1526-5900
CID: 131848